Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):864-70. doi: 10.1016/j.numecd.2012.06.003. Epub 2012 Aug 15.

Does the metabolic syndrome predict subclinical atherosclerotic damage in an asymptomatic population at intermediate cardiovascular risk?

Author information

  • 1Department of Internal Medicine, "Luigi Sacco" Hospital, University of Milan, via G.B. Grassi 74, 20154 Milan, Italy.

Abstract

BACKGROUND AND AIMS:

It is not clear whether the metabolic syndrome (MetS) is a distinct entity or a combination of risk factors. Several studies showed the association between MetS and cardiovascular disease (CVD). Subclinical target organ damage (TOD) is a recognized marker of atherosclerosis and predictor of cardiovascular events. Increased burden of subclinical atherosclerosis was detected in individuals with MetS. We thus aimed to examine the association between MetS and cumulative or specific TOD and to assess whether MetS predicts TOD better than the risk factors included in current definitions.

METHODS AND RESULTS:

We recorded TOD in 979 patients at intermediate cardiovascular risk with and without MetS according to IDF and NCEP criteria. We measured common carotid intima-media thickness, left ventricular mass index (LVMI), urine albumin to creatinine ratio (UACR), and ankle-brachial index. We found no correlation between having at least one TOD and being positive for MetS. A high UACR was associated with MetS using both IDF and NCEP criteria, while only NCEP identified individuals with increased LVMI. Using a multivariate logistic regression model including MetS, age, sex, waist circumference, triglycerides, HDL cholesterol, blood pressure and blood glucose levels we found no correlations between the presence of MetS and at least one TOD. The associations with high UACR and LVMI disappeared when age, blood pressure and glycemia were counted in.

CONCLUSION:

Although MetS showed some relation with subclinical renal and cardiac damage, it does not predict TOD any better than the risk factors specified in the definitions.

Copyright © 2012 Elsevier B.V. All rights reserved.

KEYWORDS:

Albuminuria; Atherosclerosis; Cardiovascular diseases; Carotid artery diseases; Left ventricular hypertrophy; Metabolic syndrome X; Peripheral arterial disease; Risk factors

PMID:
22901845
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk